Prior presentations: Preliminary results from these analyses were presented at the Vanderbilt University Emphasis Research Forum (poster, April 2012) and at the Vanderbilt Medical Alumni Association (plenary session, October of 2012).
First-trimester antihistamine exposure and risk of spontaneous abortion or preterm birth†
Version of Record online: 1 MAY 2014
Copyright © 2014 John Wiley & Sons, Ltd.
Pharmacoepidemiology and Drug Safety
Volume 23, Issue 10, pages 1043–1050, October 2014
How to Cite
2014), First-trimester antihistamine exposure and risk of spontaneous abortion or preterm birth, Pharmacoepidemiol Drug Saf, 23, 1043–1050, doi:10.1002/pds.3637., , , and (
- Issue online: 14 OCT 2014
- Version of Record online: 1 MAY 2014
- Manuscript Accepted: 31 MAR 2014
- Manuscript Revised: 18 FEB 2014
- Manuscript Received: 2 DEC 2013
|pds3637-sup-0001-sm_documentS1.docx||Word 2007 document||17K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.